Strengthening Investment Engagement in Rwanda Exon Genetic & Biotechnology and BEYLER GROUP have continued to engage with institutions in Rwanda as part of their interest in healthcare and investment opportunities in the country. On April 7, 2023, BEYLER GROUP Chairman of the Board Dr. Hulusi Söğütlü and Exon’s Rwanda representative
Strengthening Healthcare Investment and Biotechnology Cooperation in Rwanda Exon Genetic & Biotechnology continues to pursue opportunities that contribute to the development of healthcare, medical technology and biotechnology across Africa. As part of this commitment, the company’s leadership held an important meeting with Rwanda’s Deputy Minister of Health, Dr. Yvan Butera,
Strengthening Business Connections Between East Africa and Türkiye International cooperation plays an important role in creating opportunities for investment, technology transfer, healthcare development and knowledge exchange. Exon Genetic & Biotechnology has maintained an interest in strengthening relationships between Türkiye and African markets, particularly within East Africa. As part of these
Exon Genetic & Biotechnology Engages Uganda’s Leadership on New Investments Exon Genetic & Biotechnology and BEYLER GROUP have maintained a strong interest in Uganda as part of their wider healthcare and investment activities in East Africa. On May 25, 2022, Uganda President H.E. Yoweri Kaguta Museveni received BEYLER GROUP Chairman
